MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-AP-10-0013339
Assurgen Pharma Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹41.36 Cr
▼ 3% YoY
Net loss · FY 2025
₹2.07 Cr
Net margin -5%
EBITDA · FY 2025
₹5.09 Cr
EBITDA margin 12.3%
Authorised capital
₹80 Cr
Registered with MCA
Paid-up capital
₹75.46 Cr
Issued & subscribed
Open charges
₹23.5 Cr
Satisfied ₹23.29 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
135
Provident fund records
About Assurgen Pharma Private Limited
Data last updated:
Assurgen Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2013PTC090442. Its GSTIN is 37AAMCA3380Q1ZZ (Andhra Pradesh).
The company has an authorised share capital of ₹80 Cr and a paid-up capital of ₹75.46 Cr. It is led by directors including Nagendra Rao Kukalakunta (Managing Director) and Naveen Parupalli.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Visakhapatnam, Andhra Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.36 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹2.07 Cr (net margin -5%) and EBITDA of ₹5.09 Cr (EBITDA margin 12.3%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
The company has about 135 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Treatment Possible and Assurgen Pharma. As per MCA filings, the company has open charges of ₹23.5 Cr and satisfied charges of ₹23.29 Cr on record. Court records list 19 cases involving the company, including 10 filed by the company and 9 filed against it; 5 cases are pending. The company has 12 deals on record (6 secondary share transfers, 5 rights issues, 1 funding round), with disclosed funding of ₹4.28 Cr; the latest was in March 2022. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Jai Lara Drugs Private Limited with revenue of ₹41.75 Cr.
Assurgen Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0013339). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website assurgenpharma.com.
Company details
CIN U24232AP2013PTC090442
Registration Number 090442
Incorporation Date 10 October 2013
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-10-0013339
Key People
Nagendra Rao Kukalakunta Managing Director Naveen Parupalli Director Paidi Lakshman Rao Director Recognitions & Rankings of Assurgen Pharma
Contact details
Assurgen Pharma Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is assurgenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.23E Lalamkoduru Village Rambilli Mandal Apsez Denotified Area At, Chutapuram, Visakhapatnam, Andhra Pradesh, India – 531011
- IndustryPharma, API Manufacturers
To see the full contact details of Assurgen Pharma Private Limited, buy the company report.
Comprehensive company report
Assurgen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Assurgen Pharma operates two associated brands: Treatment Possible and Assurgen Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Standalone multi speciality clinic | treatmentpossible.com | |
| Produces high-quality active pharmaceutical ingredients (APIs). | assurgenpharma.com |
Business activity
The main business activity of Assurgen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Assurgen Pharma Private Limited, buy the company report.
Financials of Assurgen Pharma Private Limited
FY 2024 filings availableAssurgen Pharma Private Limited reported revenue of ₹41.36 Cr (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹41.36 Cr ▼ 3%
Net loss · FY 2025
₹2.07 Cr margin -5%
EBITDA · FY 2025
₹5.09 Cr margin 12.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 5%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 192%
3 years · compounded
▲ 45%
5 years · compounded
▲ 30%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 192% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.07 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.3% | ||||
| Net Profit Margin | -5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Assurgen Pharma Private Limited, buy the company report.
Board of directors of Assurgen Pharma Private Limited
Assurgen Pharma has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Parupalli | Director | 10 Oct 2013 | 13 Years 0 Months | Current |
| Paidi Lakshman Rao | Director | 15 Nov 2014 | 11 Years 11 Months | Current |
| Srinivasa Rao Vayetla | Director | 30 Nov 2017 | 8 Years 10 Months | Current |
| Johann Danklmaier | Director | 02 Jul 2024 | 2 Years 3 Months | Current |
| Ravi Kumar Potluri | Director | 20 Dec 2016 | 9 Years 10 Months | Current |
| Nagendra Rao Kukalakunta | Managing Director | 10 Oct 2013 | 13 Years 0 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Assurgen Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jai Lara Drugs Private Limited | ₹41.75 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Polydrug Laboratories Private Limited | ₹41.72 Cr (FY 2024) | 238.0% | Mumbai, Maharashtra, India | |||
| Phanicare Pharmaceuticals Private Limited | ₹41.7 Cr (FY 2024) | -18.0% | Hyderabad, Telangana, India | |||
| Qualikems Lifesciences Private Limited | ₹41.7 Cr (FY 2025) | 13.0% | Vadodara, Gujarat, India | |||
| Accrete Pharmaceuticals Private Limited | ₹41.49 Cr (FY 2025) | 19.0% | Hyderabad, Telangana, India | |||
| Assurgen Pharma Private Limitedthis company | ₹41.36 Cr (FY 2025) | -₹2.07 Cr | -5% | -3.0% | 135 | Visakhapatnam, Andhra Pradesh, India |
| Elixir Pharma Chem Private Limited | ₹41.04 Cr (FY 2025) | 86.0% | Ahmedabad, Gujarat, India | |||
| Stermone Chemicals Private Limited | ₹40.62 Cr (FY 2024) | 1.0% | Khambhat, Gujarat, India | |||
| Erythro Pharma Private Limited | ₹40.06 Cr (FY 2025) | 48.0% | Hyderabad, Telangana, India | |||
| Cureworth Drugs & Intermediates Private Limited | ₹40.05 Cr (FY 2025) | 79.0% | Panvel, Maharashtra, India | |||
| Viswa Laboratories Private Limited | ₹39.96 Cr (FY 2025) | 1.0% | Pune, Maharashtra, India |
To see the full peer comparison of Assurgen Pharma Private Limited, buy the company report.
Auditor
Assurgen Pharma Private Limited is audited by K Ramalinga Swamy & Co for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K Ramalinga Swamy & Co | FY 2021 |
Shareholding
The shareholding of Assurgen Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Assurgen Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹23.5 Cr
Satisfied charges
₹23.29 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Oct 2021 | 100514026 | Hdfc Bank Limited | ₹23.5 Cr | Open | |
| 28 Jan 2019 | 100241732 | Others | ₹80 Lakh | Satisfied | |
| 05 Aug 2017 | 100179549 | Others | ₹4 Cr | Satisfied | |
| 27 Mar 2017 | 100088373 | Others | ₹2.49 Cr | Satisfied | |
| 24 Nov 2015 | 10604135 | Andhra Pradesh State Financial Corporation. | ₹16 Cr | Satisfied |
To see the full charge records of Assurgen Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Assurgen Pharma Private Limited has 12 deals on record (6 secondary share transfers, 5 rights issues, 1 funding round), with disclosed funding of ₹4.28 Cr; the latest was in March 2022.
Total deals
12
Secondary share transfers
6
Rights issues
5
Funding round
1
Disclosed funding
₹4.28 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: G.L. Pharma GmbH Seller: 2 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Srimannaryana Traders LLP , an individual |
| May 2018 | Rights issue | ₹2.35 Cr | Investors: Srimannaryana Traders LLP , 2 individuals |
| Dec 2017 | Funding round | ₹4.28 Cr | Investors: Srimannaryana Traders LLP |
To see the full deal history of Assurgen Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Assurgen Pharma Private Limited has 19 court cases on record: 10 filed by Assurgen Pharma, 9 filed against it. 5 cases are pending and 14 are disposed.
Total cases
19
Filed by the company
10
Filed against the company
9
Pending
5
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 8 | 4 |
| High courts | 3 | 1 | 1 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Visakapatnam, Andhra Pradesh | Civil suit | Filed by the company against Qualitek Pharma Pvt.Ltd | Pending |
| High Court of Andhra Pradesh | Appeal | Filed by the company against Union of India | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed by the company against R.T.Pharma | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed by the company against M/S.P.T.Pharma | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed by the company against M/S. P.T.Pharma | Pending |
To see the full case history of Assurgen Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Assurgen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Assurgen Pharma Private Limited has a workforce of 135 employees on its EPFO records as of Mar 28, 2024, across 2 active EPFO establishments.
Employee count
135
Active EPFO establishments
2
Employee growth
7.14%
GST
Assurgen Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAMCA3380Q1ZZ | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Assurgen Pharma Private Limited, buy the company report.
Recent activity
Assurgen Pharma Private Limited has 14 board changes on record since 2013: 7 appointments and 7 cessations. The latest: Johann Danklmaier ceased to be Additional Director on 29 Sep 2024.
AGM
Assurgen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Johann Danklmaier ceased to be Additional Director.
Appointed
Johann Danklmaier was appointed as Director.
Filing
Assurgen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Ceased
Paidi Lakshman Rao ceased to be Director.
Charges
A charge with Hdfc Bank Limited of Rs. 23.50 Cr registered on 30 Oct 2021 with Charge ID 100514026 was modified on 26 Oct 2022.
Charges
A charge registered on 27 Mar 2017 via Charge ID 100088373 with Others was fully satisfied on 04 Jan 2022.
Charges
A charge registered on 24 Nov 2015 via Charge ID 10604135 with Andhra Pradesh State Financial Corporation. was fully satisfied on 04 Jan 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 23.50 Cr with Charge ID 100514026 was registered on 30 Oct 2021.
Charges
A charge registered on 05 Aug 2017 via Charge ID 100179549 with Others was fully satisfied on 01 Dec 2020.
Charges
A charge registered on 28 Jan 2019 via Charge ID 100241732 with Others was fully satisfied on 21 Aug 2019.
Appointed
Dr Georg Stark was appointed as Director.
16 earlier events are in the company report.
Frequently asked questions
Assurgen Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 October 2013 (13+ years old) and is registered under CIN U24232AP2013PTC090442.
Assurgen Pharma has 7 current directors:
- Nagendra Rao Kukalakunta - Managing Director
- Naveen Parupalli - Director
- Paidi Lakshman Rao - Director
- Srinivasa Rao Vayetla - Director
- Johann Danklmaier - Director
- Ravi Kumar Potluri - Director
- Dr Georg Stark - Director
The latest financial statements of Assurgen Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Assurgen Pharma is 37AAMCA3380Q1ZZ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Assurgen Pharma is U24232AP2013PTC090442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Assurgen Pharma has 19 court cases on record: 10 filed by the company and 9 filed against it. 5 are pending. Most are in the district courts.
Assurgen Pharma was incorporated on 10 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Vijayawada.
Assurgen Pharma has 12 deals on record (6 secondary share transfers, 5 rights issues, 1 funding round), with disclosed funding of ₹4.28 Cr; the latest was in March 2022.
The peers of Assurgen Pharma by revenue are Jai Lara Drugs Private Limited, Polydrug Laboratories Private Limited, Phanicare Pharmaceuticals Private Limited, Qualikems Lifesciences Private Limited, Accrete Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Johann Danklmaier ceased to be Additional Director on 29 Sep 2024. Johann Danklmaier was appointed as Director on 02 Jul 2024. Paidi Lakshman Rao ceased to be Director on 30 Mar 2024. Assurgen Pharma has 14 board changes on record in total.
Yes, Assurgen Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-AP-10-0013339).